Inactive Instrument

Idenix Pharmaceuticals Inc Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015	AbbVie : Merck says hepatitis C drugs to lose breakthrough status	RE
2014	Apple : Wall St. edges up, lifted by mergers, acquisitions	RE

AbbVie : Merck says hepatitis C drugs to lose breakthrough status	15-02-04	RE
Apple : Wall St. edges up, lifted by mergers, acquisitions	14-06-10	RE
Apple : U.S. futures dip, S&P 500 comes off fourth straight record	14-06-10	RE
Bank of America : Dow, S&P 500 extend string of record closes; VIX up	14-06-09	RE
Bristol Myers Squibb Co. : Bristol to take $1.8 billion charge on hepatitis C drug failure	12-08-24	RE

Idenix Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Idenix Pharmaceuticals Inc.	14-06-10	PR
Idenix Pharmaceuticals : Clinical Test Results, Improved Medical Care, and Rejection of Buyout Proposal by Medical Companies - Analyst Notes on AstraZeneca, LifePoint, Insmed, Dendreon and Idenix Pharmaceuticals	14-05-23	PR
Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case	14-03-24	GL
Idenix Pharmaceuticals Inc : Files Patent Infringement Lawsuits Against Gilead Sciences in Europe	14-03-14	GL
Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Patent Interference	14-01-29	GL

Idenix Pharmaceuticals : Merck dépasse les attentes malgré la concurrence des génériques	14-07-29
Wall Street, dopée aux M&A, finit encore en hausse	14-06-09
Dow Jones Industrial Average : Wall Street finit encore en hausse	14-06-09
Gilead Sciences : Merck & Co acquiert Idenix Pharma pour 3,85 milliards de dollars	14-06-09
Apple : Les valeurs à suivre sur les marchés américains	14-06-09

Managers	Title	Age	Since
Teresa Dahlman IRC	Investor Relations Contact	-	-
Michele Liuzzi PRN	Corporate Officer/Principal	-	-
Adel Moussa PRN	Corporate Officer/Principal	-	02-02-28

Sector

	1st Jan change	Capi.
CSL LIMITED	-5.32%	84.57B
SAMSUNG BIOLOGICS CO.,LTD.	+3.95%	39.93B
BIOGEN INC.	-26.37%	27.93B
UCB	+52.09%	24.21B
BIOMARIN PHARMACEUTICAL INC.	-6.59%	17.17B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-32.37%	13.93B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-10.45%	12.3B
INCYTE CORPORATION	-15.88%	11.84B
SWEDISH ORPHAN BIOVITRUM AB	-2.85%	7.91B